全球胰島素筆市場-預測與預測（2022-2027）

在預測期內，全球胰島素筆市場預計將以 6.26% 的複合年增長率增長。

與傳統胰島素筆相比，由於其長期的成本效益、準確性、便利性和易用性，預計未來對胰島素筆的需求將會增加。除了糖尿病保險全覆蓋的高收入國家，一些中等收入國家也開始採用先進技術。在一些歐洲國家，如法國、西班牙和德國，有醫療保險，醫生會開出胰島素筆，比胰島素注射器更具成本效益，而且成本更低。

本報告調查了全球胰島素筆市場，概述了市場、產品趨勢、用途、分銷渠道、地區和進入市場的公司概況。

目錄

第一章調查方法

第二章調查目的

第三章調查流程

第4章範圍和作用域

第 5 章報告前提條件和注意事項

第 6 章市場概述

第7章介紹

第 8 章市場機會與趨勢

• 胰島素筆的技術進步
• 對智能胰島素筆的需求不斷擴大
• 集成智能筆系統介紹

第 9 章市場增長促進劑

• 糖尿病患病率增加
• 擴大使用門診胰島素筆
• 產品發布的增長

第 10 章阻礙市場增長的因素

• 胰島素筆相關並發症
• 高成本和缺乏萬能保險的覆蓋範圍
• 大量未確診的糖尿病患者

第11章市場情況

• 市場概況
• 市場規模和預測
• 產品洞察
• 使用情況洞察
• 分銷渠道洞察
• 區域洞察
• 五力分析
• 新進入者的威脅
• 賣方的議價能力
• 買方的議價能力
• 替代威脅
• 競爭對手之間的敵對關係

第 12 章產品

• 市場概況和增長動力
• 市場概況
• 常規胰島素筆
• 智能胰島素筆

第十三章用法

• 市場概況和增長動力
• 市場概況
• 一次性胰島素筆
• 可重複使用的胰島素筆

第十四章分銷渠道

• 市場概況和增長動力
• 市場概況
• 醫院和診所
• 獨立藥房
• 在線

第15章區域

• 地區概覽
• 市場概況和增長動力

第16章歐洲

第17章北美

第18章亞太地區

第19章拉丁美洲

第20章中東/非洲

第21章競爭態勢

• 衝突概述
• 市場份額分析
• LILLY
• MEDTRONIC
• SANOFI

第22章主要企業簡介

• LILLY
• MEDTRONIC
• NOVO NORDISK
• SANOFI

第23章其他知名供應商

• BD
• BIOCON
• EMPERRA GMBH E-HEALTH TECHNOLOGIES
• GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT
• HK ZION INDUSTRY
• JIANGSU DELFU MEDICAL DEVICE
• OWEN MUMFORD
• PENDIQ
• SHANGHAI UMITAI MEDICAL TECHNOLOGY
• SUN MEDICAL PRODUCTS
• SUZHOU PENG YE MEDICAL DEVICES
• TRIONES TECHNOLOGY
• YPSOMED

第24章報告摘要

第25章定量總結

第26章附錄

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Insulin Pens Market Report

There will be an increase in demand for Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance coverage, several middle-income countries have started adopting it with advanced technologies. In some countries in Europe, for example, France, Spain, and Germany, doctors highly prescribe insulin pens under the health insurance coverage with a reasonable cutting cost, which makes it more cost-effective than insulin syringes.

The insulin pens market is expected to grow at a CAGR of 6.26% during the forecast period

GLOBAL INSULIN PENS MARKET SEGMENTATION

• The traditional insulin pens dominated the market. However, smart insulin pens are expected to increase significantly in the forecast period across the globe.
• Hospitals & Clinics dominated the distribution channel segment because of the easy access to insulin pens in the hospital pharmacies and thus doctors are increasingly prescribing insulin pens in both high- and low-income countries.

Segmentation by Product

• Traditional
• Smart

Segmentation by Usage

• Disposable
• Reusable

Segmentation by Distribution Channel

• Hospitals & Clinics
• Standalone Pharmacies
• Online

GEOGRAPHICAL OUTLOOK

• Europe dominated the market due to high prevalence of diabetes in the region. APAC region is expected to grow at faster rate in the forecast period with the CAGR of 7.26% because of the increase in awareness and the target population.

Segmentation by Geography

• Europe
• Germany
• UK
• France
• Spain
• Italy
• North America
• US
• Canada
• APAC
• China
• Japan
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Turkey
• South Africa
• Saudi Arabia
• UAE

VENDOR LANDSCAPE

• The leading vendors in the insulin pen industry are Lilly, Medtronic, Novo Nordisk, and Sanofi. The market competition is solely based on quality, quantity, technology, safety, and price.

KEY VENDORS

• Lilly
• Medtronic
• Novo Nordisk
• Sanofi

OTHER PROMINENT VENDORS

• BD
• Biocon
• Diamesco
• Emperra
• Guangzhou Medsinglong Medical Equipment
• HK Zion Industry
• Jiangsu Delfu Medical Device
• Owen Mumford
• Shanghai Umitai Medical Technology
• Sun Medical Products
• Suzhou Peng Ye Medical Technology Co., Ltd.
• Triones Technology (Guangzhou)
• Ypsomed

THE REPORT INCLUDES:

• 1. The analysis of the global Insulin Pens market provides market size and growth rate for the forecast period 2022-2027.
• 2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Insulin Pens market.
• 3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
• 4. It offers a complete overview of market segments and the regional outlook of the global Insulin Pens market.
• 5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

• 4.1 MARKET DEFINITION
• 4.1.1 INCLUSIONS
• 4.1.2 EXCLUSIONS
• 4.1.3 MARKET ESTIMATION CAVEATS
• 4.2 BASE YEAR
• 4.3 SCOPE OF THE STUDY
• 4.3.1 MARKET SEGMENTATION BY PRODUCT
• 4.3.2 MARKET SEGMENTATION BY USAGE
• 4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
• 4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

• 5.1 KEY CAVEATS
• 5.2 CURRENCY CONVERSION
• 5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

• 7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

• 8.1 TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS
• 8.2 INCREASED DEMAND FOR SMART INSULIN PENS
• 8.3 INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS

9 MARKET GROWTH ENABLERS

• 9.1 RISING PREVALENCE OF DIABETES
• 9.2 INCREASED USE OF INSULIN PENS IN AMBULATORY SETTINGS
• 9.3 GROWTH IN PRODUCT LAUNCHES

10 MARKET GROWTH RESTRAINTS

• 10.1 COMPLICATIONS ASSOCIATED WITH INSULIN PENS
• 10.2 HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE
• 10.3 LARGE POPULATIONS WITH UNDIAGNOSED DIABETES

11 MARKET LANDSCAPE

• 11.1 MARKET OVERVIEW
• 11.2 MARKET SIZE & FORECAST
• 11.2.1 PRODUCT INSIGHTS
• 11.2.2 USAGE INSIGHTS
• 11.2.3 DISTRIBUTION CHANNEL INSIGHTS
• 11.2.4 GEOGRAPHY INSIGHTS
• 11.3 FIVE FORCES ANALYSIS
• 11.3.1 THREAT OF NEW ENTRANTS
• 11.3.2 BARGAINING POWER OF SUPPLIERS
• 11.3.3 BARGAINING POWER OF BUYERS
• 11.3.4 THREAT OF SUBSTITUTES
• 11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

• 12.1 MARKET SNAPSHOT & GROWTH ENGINE
• 12.2 MARKET OVERVIEW
• 12.3 TRADITIONAL INSULIN PENS
• 12.3.1 MARKET OVERVIEW
• 12.3.2 MARKET SIZE & FORECAST
• 12.3.3 TRADITIONAL INSULIN PENS BY GEOGRAPHY
• 12.4 SMART INSULIN PENS
• 12.4.1 MARKET OVERVIEW
• 12.4.2 MARKET SIZE & FORECAST
• 12.4.3 SMART INSULIN PENS BY GEOGRAPHY

13 USAGE

• 13.1 MARKET SNAPSHOT & GROWTH ENGINE
• 13.2 MARKET OVERVIEW
• 13.3 DISPOSABLE INSULIN PENS
• 13.3.1 MARKET OVERVIEW
• 13.3.2 MARKET SIZE & FORECAST
• 13.3.3 DISPOSABLE INSULIN PENS BY GEOGRAPHY
• 13.4 REUSABLE INSULIN PENS
• 13.4.1 MARKET OVERVIEW
• 13.4.2 MARKET SIZE & FORECAST
• 13.4.3 REUSABLE INSULIN PENS BY GEOGRAPHY

14 DISTRIBUTION CHANNEL

• 14.1 MARKET SNAPSHOT & GROWTH ENGINE
• 14.2 MARKET OVERVIEW
• 14.3 HOSPITALS & CLINICS
• 14.3.1 MARKET OVERVIEW
• 14.3.2 MARKET SIZE & FORECAST
• 14.3.3 HOSPITALS & CLINICS BY GEOGRAPHY
• 14.4 STANDALONE PHARMACIES
• 14.4.1 MARKET OVERVIEW
• 14.4.2 MARKET SIZE & FORECAST
• 14.4.3 STANDALONE PHARMACIES BY GEOGRAPHY
• 14.5 ONLINE
• 14.5.1 MARKET OVERVIEW
• 14.5.2 MARKET SIZE & FORECAST
• 14.5.3 ONLINE BY GEOGRAPHY

15 GEOGRAPHY

• 15.1 GEOGRAPHIC OVERVIEW
• 15.2 MARKET SNAPSHOT & GROWTH ENGINE

16 EUROPE

• 16.1 MARKET OVERVIEW
• 16.2 MARKET SIZE & FORECAST
• 16.3 EUROPE: MARKET BY PRODUCT
• 16.4 EUROPE: MARKET BY USAGE
• 16.5 EUROPE: DISTRIBUTION CHANNEL
• 16.7 KEY COUNTRIES
• 16.7.1 GERMANY: MARKET SIZE & FORECAST
• 16.7.2 FRANCE: MARKET SIZE & FORECAST
• 16.7.3 UK: MARKET SIZE & FORECAST
• 16.7.4 ITALY: MARKET SIZE & FORECAST
• 16.7.5 SPAIN: MARKET SIZE & FORECAST

17 NORTH AMERICA

• 17.1 MARKET OVERVIEW
• 17.2 MARKET SIZE & FORECAST
• 17.3 NORTH AMERICA: MARKET BY PRODUCT
• 17.4 NORTH AMERICA: MARKET BY USAGE
• 17.5 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
• 17.7 KEY COUNTRIES
• 17.7.1 US: MARKET SIZE & FORECAST
• 17.7.2 CANADA: MARKET SIZE & FORECAST

18 APAC

• 18.1 MARKET OVERVIEW
• 18.2 MARKET SIZE & FORECAST
• 18.3 APAC: MARKET BY PRODUCT
• 18.4 APAC: MARKET BY USAGE
• 18.5 APAC: MARKET BY DISTRIBUTION CHANNEL
• 18.6 KEY COUNTRIES
• 18.6.1 CHINA: MARKET SIZE & FORECAST
• 18.6.2 JAPAN: MARKET SIZE & FORECAST
• 18.6.3 INDIA: MARKET SIZE & FORECAST
• 18.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
• 18.6.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

• 19.1 MARKET OVERVIEW
• 19.2 MARKET SIZE & FORECAST
• 19.3 LATIN AMERICA: MARKET BY PRODUCT
• 19.4 LATIN AMERICA: MARKET BY USAGE
• 19.5 LATIN: MARKET BY DISTRIBUTION CHANNEL
• 19.6 KEY COUNTRIES
• 19.6.1 BRAZIL: MARKET SIZE & FORECAST
• 19.6.2 MEXICO: MARKET SIZE & FORECAST
• 19.6.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

• 20.1 MARKET OVERVIEW
• 20.2 MARKET SIZE & FORECAST
• 20.3 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
• 20.4 MIDDLE EAST & AFRICA: MARKET BY USAGE
• 20.5 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL
• 20.6 KEY COUNTRIES
• 20.6.1 TURKEY: MARKET SIZE & FORECAST
• 20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
• 20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST
• 20.6.4 UAE: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

• 21.1 COMPETITION OVERVIEW
• 21.2 MARKET SHARE ANALYSIS
• 21.2.1 LILLY
• 21.2.2 MEDTRONIC
• 21.2.3 NOVO NORDISK
• 21.2.4 SANOFI

22 KEY COMPANY PROFILES

• 22.1 LILLY
• 22.1.1 BUSINESS OVERVIEW
• 22.1.2 PRODUCT OFFERINGS
• 22.1.3 KEY STRATEGIES
• 22.1.4 KEY STRENGTHS
• 22.1.5 KEY OPPORTUNITIES
• 22.2 MEDTRONIC
• 22.2.1 BUSINESS OVERVIEW
• 22.2.2 PRODUCT OFFERINGS
• 22.2.3 KEY STRATEGIES
• 22.2.4 KEY STRENGTHS
• 22.2.5 KEY OPPORTUNITIES
• 22.3 NOVO NORDISK
• 22.3.1 BUSINESS OVERVIEW
• 22.3.2 PRODUCT OFFERINGS
• 22.3.3 KEY STRATEGIES
• 22.3.4 KEY STRENGTHS
• 22.3.5 KEY OPPORTUNITIES
• 22.4 SANOFI
• 22.4.1 BUSINESS OVERVIEW
• 22.4.2 PRODUCT OFFERINGS
• 22.4.3 KEY STRATEGIES
• 22.4.4 KEY STRENGTHS
• 22.4.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

• 23.1 BD
• 23.1.1 BUSINESS OVERVIEW
• 23.1.2 PRODUCT OFFERINGS
• 23.2 BIOCON
• 23.2.1 BUSINESS OVERVIEW
• 23.2.2 PRODUCT OFFERINGS
• 23.3 EMPERRA GMBH E-HEALTH TECHNOLOGIES
• 23.3.1 BUSINESS OVERVIEW
• 23.3.2 PRODUCT OFFERINGS
• 23.4 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT
• 23.4.1 BUSINESS OVERVIEW
• 23.4.2 PRODUCT OFFERINGS
• 23.5 HK ZION INDUSTRY
• 23.5.1 BUSINESS OVERVIEW
• 23.5.2 PRODUCT OFFERINGS
• 23.6 JIANGSU DELFU MEDICAL DEVICE
• 23.6.1 BUSINESS OVERVIEW
• 23.6.2 PRODUCT OFFERINGS
• 23.7 OWEN MUMFORD
• 23.7.1 BUSINESS OVERVIEW
• 23.7.2 PRODUCT OFFERINGS
• 23.8 PENDIQ
• 23.8.1 BUSINESS OVERVIEW
• 23.8.2 PRODUCT OFFERINGS
• 23.9 SHANGHAI UMITAI MEDICAL TECHNOLOGY
• 23.9.1 BUSINESS OVERVIEW
• 23.9.2 PRODUCT OFFERINGS
• 23.10 SUN MEDICAL PRODUCTS
• 23.10.1 BUSINESS OVERVIEW
• 23.10.2 PRODUCT OFFERINGS
• 23.11 SUZHOU PENG YE MEDICAL DEVICES
• 23.11.1 BUSINESS OVERVIEW
• 23.11.2 PRODUCT OFFERINGS
• 23.12 TRIONES TECHNOLOGY
• 23.12.1 BUSINESS OVERVIEW
• 23.12.2 PRODUCT OFFERINGS
• 23.13 YPSOMED
• 23.13.1 BUSINESS OVERVIEW
• 23.13.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

• 24.1 KEY TAKEAWAYS
• 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

• 25.1 MARKET BY GEOGRAPHY
• 25.2 MARKET BY PRODUCT
• 25.3 MARKET BY USAGE
• 25.4 MARKET BY DISTRIBUTION CHANNEL
• 25.5 NORTH AMERICA: MARKET BY PRODUCT
• 25.6 NORTH AMERICA: MARKET BY USAGE
• 25.7 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
• 25.8 APAC: MARKET BY PRODUCT
• 25.9 APAC: MARKET BY USAGE
• 25.10 APAC: MARKET BY DISTRIBUTION CHANNEL
• 25.11 EUROPE: MARKET BY PRODUCT
• 25.12 EUROPE: MARKET BY USAGE
• 25.13 EUROPE: MARKET BY DISTRIBUTION CHANNEL
• 25.14 LATIN AMERICA: MARKET BY PRODUCT
• 25.15 LATIN AMERICA: MARKET BY USAGE
• 25.16 LATIN AMERICA: MARKET BY DISTRIBUTION CHANNEL
• 25.17 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
• 25.18 MIDDLE EAST & AFRICA: MARKET BY USAGE
• 25.19 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL

26 APPENDIX

• 26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL INSULIN PENS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 PREVALENCE OF TYPE-2 DIABETES IN ADULTS (20-79 YEARS) 2019, 2030, & 2045 BY GEOGRAPHY

EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS

EXHIBIT 5 IMPACT OF INCREASED DEMAND FOR SMART INSULIN PENS

EXHIBIT 6 TOTAL COST OF SMART INSULIN PENS & STANDARD CARE FOR NON-SEVERE HYPOGLYCEMIA IN SWEDEN ($)

EXHIBIT 7 IMPACT OF INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS

EXHIBIT 8 IMPACT OF RISING PREVALENCE OF DIABETES

EXHIBIT 9 PREVALENCE OF DIABETES IN ADULTS (20-79 AGE GROUP) ACCORDING TO IDF

EXHIBIT 10 DEATHS OF DIABETIC POPULATION IN 20-79 AGE GROUP 2019

EXHIBIT 11 IMPACT OF INCREASING USAGE OF INSULIN PENS FOR AMBULATORY PURPOSES

EXHIBIT 12 IMPACT OF GROWTH IN PRODUCT LAUNCHES

EXHIBIT 13 IMPACT OF COMPLICATIONS ASSOCIATED WITH INSULIN PENS

EXHIBIT 14 IMPACT OF HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE

EXHIBIT 15 IMPACT OF LARGE POPULATIONS WITH UNDIAGNOSED DIABETES

EXHIBIT 16 GLOBAL UNDIAGNOSED DIABETES POPULATION AGED BETWEEN 20-79 (%)

EXHIBIT 17 GLOBAL INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 18 GLOBAL INSULIN PENS MARKET SHARE BY PRODUCT 2021 & 2027 (%)

EXHIBIT 19 GLOBAL INSULIN PENS MARKET SHARE BY USAGE 2021 & 2027 (%)

EXHIBIT 20 GLOBAL INSULIN PENS MARKET SHARE BY DISTRIBUTION CHANNEL 2021 & 2027 (%)

EXHIBIT 21 GLOBAL INSULIN PENS MARKET SHARE BY GEOGRAPHY 2021 & 2027 (%)

EXHIBIT 22 FIVE FORCES ANALYSIS 2021

EXHIBIT 23 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 24 GLOBAL INSULIN PENS MARKET BY PRODUCT TYPE

EXHIBIT 25 GLOBAL INSULIN PENS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 26 GLOBAL INSULIN PENS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)

EXHIBIT 27 ADVANTAGES OF INSULIN PENS OVER SYRINGES

EXHIBIT 28 SOME TRADITIONAL INSULIN PENS OFFERED BY NOVO NORDISK

EXHIBIT 29 GLOBAL TRADITIONAL INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 30 GLOBAL TRADITIONAL INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 32 GLOBAL SMART INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL SMART INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 35 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 36 GLOBAL INSULIN PENS MARKET BY USAGE

EXHIBIT 37 GLOBAL INSULIN PENS MARKET BY USAGE: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 38 GLOBAL DISPOSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL DISPOSABLE INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 41 GLOBAL REUSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL REUSABLE INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 44 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL BY 2021 & 2027

EXHIBIT 45 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL

EXHIBIT 46 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 47 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH (%)

EXHIBIT 48 GLOBAL INSULIN PENS MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL HOSPITALS & CLINICS INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 51 GLOBAL INSULIN PENS MARKET BY STANDALONE PHARMACIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL STANDALONE PHARMACIES INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL ONLINE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL ONLINE INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY

EXHIBIT 58 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 59 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)

EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 62 EUROPE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 63 EUROPE INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 64 EUROPE INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 65 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 66 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 67 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 68 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 69 INSULIN PENS MARKET IN GERMANY 2021-2027 ($ MILLION)

EXHIBIT 70 INSULIN PENS MARKET IN FRANCE 2021-2027 ($ MILLION)

EXHIBIT 71 INSULIN PENS MARKET IN UK 2021-2027 ($ MILLION)

EXHIBIT 72 INSULIN PENS MARKET IN ITALY 2021-2027 ($ MILLION)

EXHIBIT 73 INSULIN PENS MARKET IN SPAIN 2021-2027 ($ MILLION)

EXHIBIT 74 NORTH AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 75 NORTH AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 76 NORTH AMERICA INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 77 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 78 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 81 INSULIN PENS MARKET IN US 2021-2027 ($ MILLION)

EXHIBIT 82 INSULIN PENS MARKET IN CANADA 2021-2027 ($ MILLION)

EXHIBIT 83 APAC INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 84 APAC INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 85 APAC INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 86 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 87 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 88 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 89 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 90 INSULIN PENS MARKET IN CHINA 2021-2027 ($ MILLION)

EXHIBIT 91 INSULIN PENS MARKET IN JAPAN 2021-2027 ($ MILLION)

EXHIBIT 92 INSULIN PENS MARKET IN INDIA 2021-2027 ($ MILLION)

EXHIBIT 93 INSULIN PENS MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)

EXHIBIT 94 INSULIN PENS MARKET IN AUSTRALIA 2021-2027 ($ MILLION)

EXHIBIT 95 LATIN AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 96 LATIN AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 97 LATIN AMERICA INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 98 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 99 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 100 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 101 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 102 INSULIN PENS MARKET IN BRAZIL 2021-2027 ($ MILLION)

EXHIBIT 103 INSULIN PENS MARKET IN MEXICO 2021-2027 ($ MILLION)

EXHIBIT 104 INSULIN PENS MARKET IN ARGENTINA 2021-2027 ($ MILLION)

EXHIBIT 105 MIDDLE EAST & AFRICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 106 MIDDLE EAST & AFRICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 107 MIDDLE EAST & AFRICA INSULIN PENS MARKET 2021-2027 ($ MILLION)

EXHIBIT 108 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 109 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 110 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 111 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 112 INSULIN PENS MARKET IN TURKEY 2021-2027 ($ MILLION)

EXHIBIT 113 INSULIN PENS MARKET IN SOUTH AFRICA 2021-2027 ($ MILLION)

EXHIBIT 114 INSULIN PENS MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)

EXHIBIT 115 INSULIN PENS MARKET IN UAE 2021-2027 ($ MILLION)

EXHIBIT 116 LILLY: MARKET SHARE BY GEOGRAPHY 2020 (%)

EXHIBIT 117 LILLY: TOTAL REVENUE 2018-2020 ($ MILLION)

EXHIBIT 118 MEDTRONIC: TOTAL REVENUE BY DIABETES CARE SEGMENT 2018-2020 ($ MILLION)

EXHIBIT 119 MEDTRONIC: MARKET SHARE OF DIABETES CARE BY GEOGRAPHY (%)

EXHIBIT 120 NOVO NORDISK: MARKET SHARE BY GEOGRAPHY 2020 (%)

EXHIBIT 121 NOVO NORDISK: MARKET SHARE BY SEGMENTS 2020 (%)

EXHIBIT 122 NOVO NORDISK: REVENUE 2019-2020 ($ BILLION)

EXHIBIT 123 SANOFI: MARKET SHARE BY SEGMENTS 2020 (%)

EXHIBIT 124 SANOFI: TOTAL REVENUE BY PHARMACEUTICAL SEGMENT 2018-2020 ($ MILLION)

EXHIBIT 125 SANOFI: MARKET SHARE OF PHARMACEUTICAL SEGMENT BY GEOGRAPHY 2020 (%)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015-2021

TABLE 3 ADVANTAGES & DISADVANTAGES OF INSULIN PENS

TABLE 4 OVERVIEW OF INSULIN PEN ATTACHMENTS

TABLE 5 KEY ADVANCED INSULIN PENS IN MARKET

TABLE 6 OVERVIEW OF SMART CAPS

TABLE 7 GLOBAL DIABETES MARKET SIZE ($ MILLION)

TABLE 8 FACTORS INCREASING DIABETES PREVALENCE WORLDWIDE

TABLE 9 INSULIN PENS LAUNCHED IN RECENT YEARS

TABLE 10 AVERAGE PRICE OF INSULIN PENS & INSULIN VIALS PER PACKAGE & PER MONTH

TABLE 11 TRADITIONAL INSULIN PENS OFFERED BY OTHER COMPANIES

TABLE 12 SMART INSULIN PENS FROM VARIOUS COMPANIES

TABLE 13 LIST OF COMMONLY USED DISPOSABLE INSULIN PENS

TABLE 14 LIST OF COMMONLY USED REUSABLE INSULIN PENS

TABLE 15 LILLY: MAJOR PRODUCT OFFERINGS

TABLE 16 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 17 NOVO NORDISK: MAJOR PRODUCT OFFERINGS

TABLE 18 SANOFI: MAJOR PRODUCT OFFERINGS

TABLE 19 BD: MAJOR PRODUCT OFFERINGS

TABLE 20 BIOCON: MAJOR PRODUCT OFFERINGS

TABLE 21 EMPERRA GMBH E-HEALTH TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 22 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT: MAJOR PRODUCT OFFERINGS

TABLE 23 HK ZION INDUSTRY: MAJOR PRODUCT OFFERINGS

TABLE 24 JIANGSU DELFU MEDICAL DEVICE: MAJOR PRODUCT OFFERINGS

TABLE 25 OWEN MUMFORD: MAJOR PRODUCT OFFERINGS

TABLE 26 PENDIQ: MAJOR PRODUCT OFFERINGS

TABLE 27 SHANGHAI UMITAI MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 28 SUN MEDICAL PRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 29 SUZHOU PENG YE MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS

TABLE 30 TRIONES TECHNOLOGY (GUANGZHOU): MAJOR PRODUCT OFFERINGS

TABLE 31 YPSOMED: MAJOR PRODUCT OFFERINGS

TABLE 32 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 33 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 34 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 35 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 36 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 37 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 38 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 39 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 40 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 41 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 42 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 43 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 44 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 45 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 46 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 47 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 48 APAC INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 49 APAC INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 50 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 51 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 52 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 53 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 54 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 55 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 56 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 57 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 58 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 59 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 60 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 61 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 62 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 63 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 64 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 65 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 66 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 67 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 68 MIDDLE EAST & AFRICA MARKET INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 69 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)